moxonidine has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blue, DR; Dillon, MP; Eglen, RM; Jasper, JR; Lesnick, JD; MacLennan, SJ; Zhu, QM | 1 |
1 other study(ies) available for moxonidine and guanosine 5'-o-(3-thiotriphosphate)
Article | Year |
---|---|
alpha 2A-adrenoceptors, not I1-imidazoline receptors, mediate the hypotensive effects of rilmenidine and moxonidine in conscious mice. In vivo and in vitro studies.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cell Line; Dogs; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypotension; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxazoles; Quinolizines; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Saphenous Vein; Transfection | 1999 |